Progress of pazopanib in clinical applications and adverse drug reaction / 药学实践杂志
Journal of Pharmaceutical Practice
;
(6): 497-500, 2016.
Artigo
em Chinês
| WPRIM
| ID: wpr-790666
ABSTRACT
Pazopanib is a multi-targeted tyrosine kinase inhibitor ,and is mainly used to treat renal cell carcinoma ,ovari-an cancer ,breast cancer ,and lung cancer .The researchers also found that pazopanib may cause diarrhea ,hypertension ,hair loss ,nausea ,and anorexia .This paper reviewed pazopanib clinical application and adverse reactions ,and provided a basis for this medication .
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Pharmaceutical Practice
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS